PHAXIAM Therapeutics S.A. Finance Costs
PHAXIAM Therapeutics S.A. reported Finance Costs of EUR 342.00 thousand for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-26.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:FinanceCosts · last filed 2023-09-26
| Period end | Finance Costs 6 month | Finance Costs 12 month | Finance Costs 12 month as first filed |
|---|---|---|---|
| 2023-06-30 | 342.00K EUR 6-K · filed 2023-09-26 | ||
| 2022-12-31 | 1.36M EUR 20-F · filed 2023-03-28 | ||
| 2022-06-30 | 750.00K EUR 6-K · filed 2023-09-26 | ||
| 2021-12-31 | 2.70M EUR 20-F · filed 2023-03-28 | ||
| 2021-06-30 | 1.79M EUR 6-K · filed 2022-09-12 | ||
| 2020-12-31 | 5.35M EUR 20-F · filed 2023-03-28 | ||
| 2020-06-30 | 265.00K EUR 6-K · filed 2021-09-20 | ||
| 2019-12-31 | 1.53M EUR 20-F · filed 2022-04-27 | ||
| 2019-06-30 | 305.00K EUR 6-K · filed 2020-09-21 | ||
| 2018-12-31 | 28.00K EUR 20-F · filed 2021-03-08 | 29.00K EUR 20-F · filed 2019-03-29 | |
| 2018-06-30 | 42.00K EUR 6-K · filed 2019-09-26 | ||
| 2017-12-31 | 3.18M EUR 20-F · filed 2020-03-18 | ||
| 2016-12-31 | 70.00K EUR 20-F · filed 2019-03-29 | ||
| 2015-12-31 | 64.00K EUR 20-F/A · filed 2018-05-23 |